Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men

American Journal of Clinical Nutrition

Volumn 68, Issue 3, 1998, Pages 525-530

  Näslund, Erik ^a   Gutniak, Mark ^b   Skogar, Staffan ^b   Rössner, Stephan ^b   Hellström, Per M ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b NONE

Author keywords

C peptide; Food intake; Gastric emptying; GLP 1; Glucagon; Glucagon like peptide 1; Glucose; Humans; Insulin; Men; Obesity; Satiety; Visual analogue scales

Indexed keywords

C PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOOD INTAKE; GLUCOSE METABOLISM; HORMONE ACTION; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HUNGER; MALE; OBESITY; SATIETY; STATISTICAL ANALYSIS; STOMACH EMPTYING;

EID: 0031695395     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.3.525     Document Type: Article

References (42)

1. Blundell JE, Lawton CL, Hill AJ. Mechanisms of appetite control and their abnormalities in obese patients. Horm Res 1993; 39(suppl):72-6.
2. Morley JE. Appetite regulation by gut peptides. Annu Rev Nutr 1990;10:383-95.
3. Mei N, Lucchini S. Current data and ideas on digestive sensitivity. J Auton Nerv Syst 1992;41:15-8.
4. Read NW. Feedback regulation and sensation. Dig Dis Sci 1994;39:37s-40s.
5. Geiselman PJ. Control of food intake. Endocrinol Metab Clin North Am 1996;25:815-29.
6. Holst JJ. Entroglucagon. Annu Rev Physiol 1997;59:257-71.
7. Bell GI, Santerre RF, Mullenbach GT. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 1983;302:716-8.
8. Jin SLC, Han VKM, Simmons JG, Towle AC, Lauder JM, Lund PK. Distribution of glucagon-like peptide-1 (GLP-1), glucagon and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 1988;271:519-32.
9. Kreymann B, Ghatei MA, Burnett P, et al. Characterization of glucagon-like peptide 1(7-36) amide in the hypothalamus. Brain Res 1989;502:325-31.
10. Shimizu I, Hirota M, Ohboshi C, Shima K. Identification and localization of glucagon-like peptide 1 and its receptor in rat brain. Endocrinology 1987;121:1076-82.
11. Kanse SM, Kreymann B, Ghatei MA, Bloom SR. Identification and characterisation of glucagon-like peptide 1(7-36amide) binding sites in the rat brain and lung. FEBS Lett 1988;241:209-14.
12. Göke R, Larsen PH, Mikkelsen JD, Sheikh SP. Identification of specific binding sites for GLP-1(7-36)amide on the posterior lobe of the rat pituitary. J Neuroendocrinol 1995;62:130-4.
13. Göke R, Larsen PH, Mikkelsen JD, Sheikh SP. Distribution of GLP-1-(7-36) binding sites in the rat brain. Eur J Neurosci 1995;7:2294-300.
14. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 1993;7:673-86.
15. Leibowitz SF. Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends Neurosci 1992;15:491-7.
16. 2 in the central control of feeding behaviour. Digestion 1994;54:360-1.
17. Tang-Christensen M, Larsen PJ, Göke R, et al. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 1996;271:R848-56.
18. Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996;379:69-72.
19. Bloom SR. Glucagon-like peptide-1 and satiety. Reply to Van Dijk G, Thiele TE, Seeley RJ, Woods SC, Bernstein IL. Nature 1997;385:214 (letter).
20. Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R, Marks V. Attenuated GLP-1 secretion in obesity: cause or consequence. Gut 1996;38:916-9.
21. Näslund E, Grybäck P, Backman L, et al. Small bowel gut hormones: correlation to fasting antroduodenal motility and gastric emptying. Dig Dis Sci 1998;43:945-52.
22. Barkeling B, Rössner S, Björvell H. Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automated computerized monitoring on subsequent food intake. Int J Obes 1990;14:743-51.
23. Blundell J, Rogers P, Hill A. Evaluating the satiating power of foods: implications for acceptance and consumption. In: Solms J, ed. Chemical composition and sensory properties of food and their influence on nutrition. London: Academic Press, 1988:205-19.
24. Heading RC, Nimmo J, Prescott LF, Tothill P. The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol 1973;47:415-21.
25. Holst JJ. Evidence that enteroglucagon (II) is identical with the C-terminal sequence of (residue 33-69) of glicentin. Biochem J 1982;207:381-8.
26. Gutzweiler JP, Göke B, Drewe J, et al. Glucagon-like peptide-1 is a physiologic regulator of food intake in humans. Gastroenterology 1997;112:A1153 (abstr).
27. Flint A, Raben A, Holst JJ, Astrup A. Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998;101:515-20.
28. Van Dijk G, Thiele TE, Donahey JCK, et al. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. Am J Physiol 1996;271:R1096-100.
29. Drewe J, Fricker G, Huwyler J, Gutman H, Török M, Berglinger C. Is peripheral postprandially released glucagon-like peptide-1 able to cross the blood-brain barrier? Gastroenterology 1997;112:A1144 (abstr).
30. Wettergren A, Wøjdemann M, Meisner S, Stadil F, Holst JJ. The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation. Gut 1997;40:597-601.
31. Ørskov C, Poulsen SS, Møller M, Holst JJ. GLP-1 receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide-1. Diabetes 1996;45:832-5.
32. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic function in man. Dig Dis Sci 1993; 38:665-73.
33. Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S. Glucagon-like peptide 1 enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Diabetes Care 1996;19:857-63.
34. Nauck MA, Niedereichholz U, Ettler R, et al. Glucagon-like peptide-1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 1997;273:E981-8.
35. Khan MI, Read NW. The effect of duodenal lipid infusions upon gastric pressure and sensory responses to balloon distension. Gastroenterology 1992;102:467-73.
36. Sepple CP, Read NW. Gastrointestinal correlates of the development of hunger in man. Appetite 1989;13:183-91.
37. Schwartz GJ, Moran TH. Sub-diaphragmatic vagal afferent integration of meal-related gastrointestinal signals. Neurosci Biobehav Rev 1996;20:47-56.
38. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987; 2:1300-3.
39. Tordoff MG, Friedman MI. Hepatic portal glucose infusions decrease food intake and increase food preference. Am Physiol 1986;251:R192-6.
40. Schwartz MW, Bergman RN, Kahn SE, et al. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. J Clin Invest 1991;88:1271-81.
41. Woods SC, Lotter EC, McKay LD, Porte D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight in baboons. Nature 1979;282:503-5.
42. Thiele TE, Van Dijk G, Campfield LA, et al. Central infusion of GLP-1, but not leptin, produces conditioned taste aversion in rats. Am J Physiol 1997;272:R726-30.